Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | SELP | P16109 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | PTAFR | P25105 | 1/20 | 0.30 |
| ▸ | PPP5C | P53041 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17550987 | 1.00 | L3MBTL1 (0.53) | L3MBTL1KMT2AMEN1ALDH1A1SELP | |
| SCHEMBL17550989 | 1.00 | L3MBTL1 (0.53) | L3MBTL1KMT2AMEN1ALDH1A1SELP | |
| SCHEMBL10073953 | 0.96 | L3MBTL1 (0.47) | L3MBTL1KMT2AMEN1ALDH1A1SELP | |
| SCHEMBL17636518 | 0.96 | L3MBTL1 (0.47) | L3MBTL1KMT2AMEN1ALDH1A1SELP | |
| SCHEMBL6948290 | 0.91 | L3MBTL1 (0.59) | L3MBTL1KMT2AMEN1ALDH1A1SELP | |
| SCHEMBL19682312 | 0.90 | L3MBTL1 (0.53) | L3MBTL1KMT2AMEN1ALDH1A1SELP | |
| SCHEMBL15197977 | 0.88 | L3MBTL1 (0.43) | L3MBTL1KMT2AMEN1ALDH1A1SELP | |
| SCHEMBL9909443 | 0.88 | L3MBTL1 (0.43) | L3MBTL1KMT2AMEN1ALDH1A1SELP | |
| SCHEMBL17550995 | 0.88 | L3MBTL1 (0.43) | L3MBTL1KMT2AMEN1ALDH1A1SELP | |
| SCHEMBL9909432 | 0.88 | L3MBTL1 (0.43) | L3MBTL1KMT2AMEN1ALDH1A1SELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160060365-A1 | HEPARAN SULFATE SYNTHESIS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2016-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160060365-A1 | HEPARAN SULFATE SYNTHESIS | HPSE, STT3B, DDOST | L3MBTL1 3217/4885KMT2A 2909/4885MEN1 2023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.